Hypermethylation of CD19 promoter enables antigen-negative escape to CART-19 in vivo and in vitro.
Ledererova A, Dostalova L, Kozlova V, Peschelova H, Ladungova A, Culen M, Loja T, Verner J, Pospisilova S, Smida M, Mancikova V.
Ledererova A, et al. Among authors: dostalova l.
J Immunother Cancer. 2021 Aug;9(8):e002352. doi: 10.1136/jitc-2021-002352.
J Immunother Cancer. 2021.
PMID: 34413165
Free PMC article.